- Home
- ACIU vs AEYE Comparison
ACIU vs AEYE Comparison
Compare ACIU & AEYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACIU | AEYE |
|---|---|---|
| Founded | 2003 | 2005 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 213.3M | 170.9M |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | ACIU | AEYE |
|---|---|---|
| Price | $3.70 | $9.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $10.00 | ★ $22.00 |
| AVG Volume (30 Days) | ★ 402.0K | 132.4K |
| Earning Date | 03-12-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $5,482,957.00 | ★ $39,540,000.00 |
| Revenue This Year | N/A | $16.79 |
| Revenue Next Year | $644.42 | $11.30 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 18.57 |
| 52 Week Low | $1.43 | $8.63 |
| 52 Week High | $4.00 | $20.57 |
Technical Indicators
Market Signals| Indicator | ACIU | AEYE |
|---|---|---|
| Relative Strength Index (RSI) | 59.56 | 38.49 |
| Support Level | $3.24 | $8.63 |
| Resistance Level | $3.80 | $10.21 |
| Average True Range (ATR) | 0.27 | 0.51 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 67.42 | 49.29 |
Price Performance
Historical ComparisonAbout ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About AEYE AudioEye Inc.
AudioEye Inc is a software solution provider delivering immediate ADA and WCAG accessibility compliance at scale. Through patented technology, subject matter expertise and proprietary processes, it is eradicating all barriers to digital accessibility, helping creators get accessible and supporting them with ongoing advisory and automated upkeep. Trusted by the ADP, Tommy Hilfiger, A360 Media, Samsung, Landry's and others. It helps everyone identify and resolve issues of accessibility and enhance user experiences, automating digital accessibility for the widest audiences.